This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| NASA Twins Study | |
|---|---|
| Title | NASA Twins Study |
| Caption | Scott and Mark Kelly during preparation for the study |
| Date | 2015–2016 |
| Location | International Space Station, Houston, Texas |
| Participants | Scott Kelly, Mark Kelly |
| Organizations | National Aeronautics and Space Administration, European Space Agency, Japanese Aerospace Exploration Agency |
NASA Twins Study
The NASA Twins Study examined physiological, molecular, cognitive, and behavioral changes in identical twin astronauts Scott Kelly and Mark Kelly during Scott's year-long mission aboard the International Space Station while Mark remained on Earth, coordinated by the National Aeronautics and Space Administration with collaborators including the European Space Agency, the Japanese Aerospace Exploration Agency, and the Smithsonian Institution. The project integrated clinical measures, multi-omics profiling, neurocognitive testing, and environmental monitoring to assess spaceflight effects relevant to long-duration missions such as those planned for Artemis program and crewed missions to Mars.
The study focused on identical twin astronauts Scott Kelly and Mark Kelly and involved institutions such as the Johnson Space Center, the Warren Grant Magnuson Clinical Center, and the National Institutes of Health to compare in-flight and Earth-bound baselines across genetics, epigenetics, transcriptomics, proteomics, metabolomics, microbiomics, and immunology; it informed operational planning by organizations including SpaceX, Roscosmos State Corporation for Space Activities, and the Canadian Space Agency. The multidisciplinary cohort included researchers from the Broad Institute, the Salk Institute, and the European Molecular Biology Laboratory who coordinated sample collection, sequencing, and data sharing compatible with policies from the Office of Science and Technology Policy.
Scott Kelly spent 340 consecutive days aboard the International Space Station under a mission framework designed by NASA Johnson Space Center flight surgeons; Mark Kelly served as the Earth-based control with synchronized clinical testing at facilities such as the Walter Reed National Military Medical Center and the Mount Sinai Health System. The experimental design used preflight, inflight, and postflight sampling schedules aligned with standards from the World Health Organization and analytical workflows implemented at the National Human Genome Research Institute and the National Aeronautics and Space Administration Ames Research Center. Environmental controls, dietary monitoring, and exercise countermeasures were documented alongside radiation dosimetry from instruments provided by the European Space Agency and models from the National Council on Radiation Protection and Measurements.
Researchers reported shifts in telomere length, DNA methylation patterns, gene expression, immune function, and microbiome composition measured by platforms at the Broad Institute, the Salk Institute, and the National Institutes of Health Clinical Center; these molecular changes were compared with astronaut studies archived by the Johnson Space Center and contextualized against studies from the Twin Research Centre and population cohorts from the UK Biobank. Alterations included transient telomere elongation followed by postflight shortening, immune perturbations affecting cytokine profiles measured at the Cleveland Clinic, and microbiome shifts analyzed in collaboration with the Earth Microbiome Project.
Neurocognitive testing administered using batteries developed by collaborators at the University of Pennsylvania, the Massachusetts Institute of Technology, and the University of California, San Diego detected changes in attention, speed, and spatial orientation that paralleled findings from long-duration analogs conducted by the European Space Agency and psychological assessments used by the United States Air Force. Behavioral monitoring incorporated sleep studies and actigraphy protocols validated by the National Sleep Foundation and cognitive neuroscience methods from the National Institute of Mental Health.
The study informed assessment of spaceflight risks such as bone density loss observed in studies at the National Institutes of Health and vestibular dysfunction documented in research from the Mayo Clinic, supporting countermeasures including resistive exercise regimens developed with the Johnson Space Center and nutritional interventions advised by the American Dietetic Association. Radiation exposure modelling referenced analyses from the NASA Space Radiation Laboratory and international standards from the International Commission on Radiological Protection to evaluate carcinogenesis risk and cognitive effects relevant to future missions by organizations like Boeing and Blue Origin.
Data integration employed multi-omics pipelines from the Broad Institute, statistical frameworks from the University of Washington, and computational resources at the Oak Ridge National Laboratory and NASA Advanced Supercomputing Division, with quality control and reproducibility standards informed by the National Academies of Sciences, Engineering, and Medicine. Analytical approaches combined longitudinal mixed-effects models used in cohort studies at the Framingham Heart Study and network analysis methods from the European Bioinformatics Institute to dissect individual-specific and shared responses.
Findings influenced planning for long-duration exploration missions such as Artemis program lunar sorties and proposed crewed voyages to Mars, spurring follow-up studies at the Johnson Space Center, expanded cohorts including international partners like the Canadian Space Agency and Roscosmos State Corporation for Space Activities, and mechanistic research at institutions such as the Salk Institute and the Broad Institute. Future research priorities include larger astronaut cohorts, extended multi-omics time series coordinated with the International Space Station research schedule, and translational efforts linking spaceflight biology to terrestrial medicine programs at the National Institutes of Health and academic medical centers.
Category:Space medicine